Intermediate for Olaparib. Olaparib (trade name Lynparza) is a PARP inhibitor for the treatment of germline BRCA mutated (gBRCAm) advanced ovarian cancer that has received three or more prior lines of chemotherapy. Olaparib has been approved by the U.S Food and Drug Administration on December 19, 2014.


Product Name:                  1-(Cyclopropylcarbonyl)piperazine

Synonyms:                         N/A

CAS Number:                     59878-57-8

Molecular Weight:            154.2114

Molecular Formula:          C8H14N2O

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=C(C1CC1)N1CCNCC1

  • $138.00
  • Ex Tax: $138.00

Available Options